Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
8695 | 1227 | 43.6 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
385 | 3 | MICROGLIA//MAGNETIC RESONANCE SPECTROSCOPY//LITHIUM | 31368 |
1808 | 2 | LITHIUM//GLYCOGEN SYNTHASE KINASE 3//GSK 3 | 6256 |
8695 | 1 | LITHIUM//IST SCI HSR//MOL NEUROPSYCHOPHARMACOL PROGRAM | 1227 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | LITHIUM | authKW | 192254 | 18% | 3% | 224 |
2 | IST SCI HSR | address | 149307 | 0% | 100% | 6 |
3 | MOL NEUROPSYCHOPHARMACOL PROGRAM | address | 99538 | 0% | 100% | 4 |
4 | MANIA | authKW | 86806 | 6% | 4% | 79 |
5 | TRIMERIC GTP BINDING PROTEIN | authKW | 74654 | 0% | 100% | 3 |
6 | BIPOLAR AFFECTIVE DISORDER | authKW | 65786 | 3% | 8% | 32 |
7 | BIPOLAR DISORDER | authKW | 56959 | 12% | 2% | 146 |
8 | CELLULAR MOL PATHOPHYSIOL | address | 52677 | 1% | 18% | 12 |
9 | FORMYLMETHIONYLLEUCYLPHENYLALANINE | authKW | 49769 | 0% | 100% | 2 |
10 | G ALPHA Q 11 SIGNALLING | authKW | 49769 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Psychiatry | 20146 | 46% | 0% | 565 |
2 | Neurosciences | 12246 | 58% | 0% | 706 |
3 | Pharmacology & Pharmacy | 5546 | 40% | 0% | 489 |
4 | Clinical Neurology | 1419 | 16% | 0% | 196 |
5 | Behavioral Sciences | 190 | 3% | 0% | 40 |
6 | Psychology | 155 | 3% | 0% | 36 |
7 | Biochemistry & Molecular Biology | 37 | 10% | 0% | 118 |
8 | Medicine, Research & Experimental | 25 | 3% | 0% | 36 |
9 | Toxicology | 20 | 2% | 0% | 25 |
10 | Psychology, Clinical | 8 | 1% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IST SCI HSR | 149307 | 0% | 100% | 6 |
2 | MOL NEUROPSYCHOPHARMACOL PROGRAM | 99538 | 0% | 100% | 4 |
3 | CELLULAR MOL PATHOPHYSIOL | 52677 | 1% | 18% | 12 |
4 | SECT BIOCHEM PSYCHIAT | 32489 | 1% | 16% | 8 |
5 | MOL PATHOPHYSIOL | 29303 | 2% | 6% | 21 |
6 | ABT PSCYHIAT PSYCHOTHER IE POLIKLIN | 24885 | 0% | 100% | 1 |
7 | BEACON DIAGNOST | 24885 | 0% | 100% | 1 |
8 | BETRIEBSSTATTE UETERSEN | 24885 | 0% | 100% | 1 |
9 | BIOCHEM PSYCHIAT SECT250 ST | 24885 | 0% | 100% | 1 |
10 | CATEDRAT BIOQUIM BIOL MOL | 24885 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOLOGICAL PSYCHIATRY | 21742 | 7% | 1% | 89 |
2 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 5829 | 3% | 1% | 34 |
3 | JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION | 5692 | 1% | 2% | 12 |
4 | NEUROPSYCHOPHARMACOLOGY | 5626 | 3% | 1% | 34 |
5 | NEUROPSYCHOBIOLOGY | 5509 | 2% | 1% | 23 |
6 | PSYCHOPHARMACOLOGY | 5508 | 4% | 0% | 52 |
7 | INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 5067 | 2% | 1% | 19 |
8 | JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY | 4899 | 1% | 1% | 14 |
9 | EUROPEAN NEUROPSYCHOPHARMACOLOGY | 4814 | 2% | 1% | 21 |
10 | NEUROPHARMACOLOGY | 4414 | 3% | 0% | 41 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LITHIUM | 192254 | 18% | 3% | 224 | Search LITHIUM | Search LITHIUM |
2 | MANIA | 86806 | 6% | 4% | 79 | Search MANIA | Search MANIA |
3 | TRIMERIC GTP BINDING PROTEIN | 74654 | 0% | 100% | 3 | Search TRIMERIC+GTP+BINDING+PROTEIN | Search TRIMERIC+GTP+BINDING+PROTEIN |
4 | BIPOLAR AFFECTIVE DISORDER | 65786 | 3% | 8% | 32 | Search BIPOLAR+AFFECTIVE+DISORDER | Search BIPOLAR+AFFECTIVE+DISORDER |
5 | BIPOLAR DISORDER | 56959 | 12% | 2% | 146 | Search BIPOLAR+DISORDER | Search BIPOLAR+DISORDER |
6 | FORMYLMETHIONYLLEUCYLPHENYLALANINE | 49769 | 0% | 100% | 2 | Search FORMYLMETHIONYLLEUCYLPHENYLALANINE | Search FORMYLMETHIONYLLEUCYLPHENYLALANINE |
7 | G ALPHA Q 11 SIGNALLING | 49769 | 0% | 100% | 2 | Search G+ALPHA+Q+11+SIGNALLING | Search G+ALPHA+Q+11+SIGNALLING |
8 | LITHIUM WITHDRAWAL | 49769 | 0% | 100% | 2 | Search LITHIUM+WITHDRAWAL | Search LITHIUM+WITHDRAWAL |
9 | MRNA D 2 | 49769 | 0% | 100% | 2 | Search MRNA+D+2 | Search MRNA+D+2 |
10 | NECA AGONIST | 49769 | 0% | 100% | 2 | Search NECA+AGONIST | Search NECA+AGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, G , HASANAT, KA , BEBCHUK, JM , MOORE, GJ , GLITZ, D , MANJI, HK , (1999) REGULATION OF SIGNAL TRANSDUCTION PATHWAYS AND GENE EXPRESSION BY MOOD STABILIZERS AND ANTIDEPRESSANTS.PSYCHOSOMATIC MEDICINE. VOL. 61. ISSUE 5. P. 599 -617 | 93 | 65% | 50 |
2 | GOULD, TD , MANJI, HK , (2002) SIGNALING NETWORKS IN THE PATHOPHYSIOLOGY AND TREATMENT OF MOOD DISORDERS.JOURNAL OF PSYCHOSOMATIC RESEARCH. VOL. 53. ISSUE 2. P. 687-697 | 71 | 66% | 67 |
3 | BEZCHLIBNYK, Y , YOUNG, LT , (2002) THE NEUROBIOLOGY OF BIPOLAR DISORDER: FOCUS ON SIGNAL TRANSDUCTION PATHWAYS AND THE REGULATION OF GENE EXPRESSION.CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE. VOL. 47. ISSUE 2. P. 135-148 | 79 | 54% | 38 |
4 | JOPE, RS , (1999) ANTI-BIPOLAR THERAPY: MECHANISM OF ACTION OF LITHIUM.MOLECULAR PSYCHIATRY. VOL. 4. ISSUE 2. P. 117 -128 | 67 | 49% | 253 |
5 | SCHREIBER, G , AVISSAR, S , (2003) APPLICATION OF G-PROTEINS IN THE MOLECULAR DIAGNOSIS OF PSYCHIATRIC DISORDERS.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 3. ISSUE 1. P. 69-80 | 50 | 72% | 10 |
6 | LENOX, RH , HAHN, CG , (2000) OVERVIEW OF THE MECHANISM OF ACTION OF LITHIUM IN THE BRAIN: FIFTY-YEAR UPDATE.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 61. ISSUE . P. 5 -15 | 59 | 56% | 88 |
7 | MANJI, HK , LENOX, RH , (2000) THE NATURE OF BIPOLAR DISORDER.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 61. ISSUE . P. 42 -57 | 55 | 59% | 63 |
8 | CORBELLA, B , VIETA, E , (2003) MOLECULAR TARGETS OF LITHIUM ACTION.ACTA NEUROPSYCHIATRICA. VOL. 15. ISSUE 6. P. 316-340 | 87 | 35% | 16 |
9 | MANJI, HK , LENOX, RH , (2000) SIGNALING: CELLULAR INSIGHTS INTO THE PATHOPHYSIOLOGY OF BIPOLAR DISORDER.BIOLOGICAL PSYCHIATRY. VOL. 48. ISSUE 6. P. 518 -530 | 43 | 68% | 106 |
10 | PEREZ, J , TARDITO, D , MORI, S , RACAGNI, G , SMERALDI, E , ZANARDI, R , (2000) ABNORMALITIES OF CAMP SIGNALING IN AFFECTIVE DISORDERS: IMPLICATIONS FOR PATHOPHYSIOLOGY AND TREATMENT.BIPOLAR DISORDERS. VOL. 2. ISSUE 1. P. 27 -36 | 53 | 58% | 34 |
Classes with closest relation at Level 1 |